Benjamin N Jones

1PUBLICATIONS
6CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Nov 04, 2024
Ligand-centred phenotype-driven development of potent kinase inhibitors against oesophageal cancer.

Cecilia C Ayala-Aguilera, Yang Ge, Álvaro Lorente-Macías

Pageof 1

Frequent Collaborators

1 joint publications

Cecilia C Ayala-Aguilera

1 joint publications

Yang Ge

1 joint publications

Álvaro Lorente-Macías

1 joint publications

Catherine Adam

1 joint publications

Neil O Carragher

1 joint publications

Asier Unciti-Broceta

Frequent Collaborators

1 joint publications

Cecilia C Ayala-Aguilera

1 joint publications

Yang Ge

1 joint publications

Álvaro Lorente-Macías

1 joint publications

Catherine Adam

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

7.9K
See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

7.9K
See more related videos